comparemela.com

Alerts Drug News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China introduces new IP mediation rules in latest bid to play a greater role in cross-border disputes

Guidelines unveiled by semi-governmental trade body are country’s first IP-specific rules for a tool Chinese patent implementers say they favour

Key takeaways from Merck s landmark covid IP licensing deal with the Medicines Patent Pool

The agreement is the first granting non-exclusive and royalty free rights to sub-licensees of a covid therapeutic or vaccine

Apple s attack on PTAB discretionary denials is teed up for US Supreme Court

The USPTO opposes the iPhone giant’s cert petition, but the company has drawn wide support from implementers that want to take down the NHK-Fintiv rule

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.